Halozyme Therapeutics Inc (HALO)
46.82
-0.11
(-0.23%)
USD |
NASDAQ |
Dec 23, 12:06
Halozyme Therapeutics Free Cash Flow: 392.71M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lexicon Pharmaceuticals Inc | -208.39M |
| Novavax Inc | -112.35M |
| Kura Oncology Inc | -169.24M |
| TransMedics Group Inc | -120.51M |
| Pulmonx Corp | -34.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 115.38M |
| Cash from Investing (Quarterly) | -167.48M |
| Cash from Financing (Quarterly) | 18.56M |
| Free Cash Flow Per Share (Quarterly) | 0.8749 |
| Free Cash Flow to Equity (Quarterly) | 112.22M |
| Free Cash Flow to Firm (Quarterly) | 117.61M |
| Free Cash Flow Yield | 6.46% |